A public health official proposes a long-term program to completely eliminate the gene responsible for sickle-cell conditions from a population living in a region where malaria is the leading cause of death. Based on the health characteristics of individuals who are carriers (possessing one copy of the gene), evaluate the potential negative consequences of this program on the community's resilience to disease.

Google

Sickle-cell carriers are individuals who have inherited a single copy of the sickle-cell gene. Rather than experiencing the severe full-blown disease associated with having two gene copies, carriers usually only face minor health problems or symptoms triggered by extreme conditions like severe dehydration or oxygen deprivation. A crucial trait of these carriers is their natural protection against malaria, resulting from blood chemistry and immune alterations that suppress the parasite. This protective immunity is absent in individuals with full-blown sickle-cell anemia.

Characteristics of Sickle-Cell Carriers

A narrative example demonstrates how the adaptiveness of the sickle-cell mutation relies on the environment. In a malaria-prevalent region, two sisters, Luwi and Sena, are exposed to malaria. Luwi, a carrier of the sickle-cell mutation, is protected and survives, while Sena, lacking the mutation, succumbs to the disease. Luwi's survival, which allows her to reproduce, highlights the mutation's high adaptiveness in her African homeland. Conversely, if Luwi lived in the United States, where malaria is rare, the mutation would be costly—offering no health benefits while causing minor health issues for her and a high probability of sickle-cell disease in her descendants.

Example of Survival Advantage for Sickle-Cell Carriers

The adaptive advantage of the sickle-cell mutation is contingent upon the geographic environment. In areas where malaria is widespread, like parts of Africa, possessing a single copy of the sickle-cell mutation is beneficial because it protects the carrier from malaria. Conversely, in regions where malaria is scarce, such as the United States, the sickle-cell gene provides no health benefits. In these environments, the mutation is a liability: carriers with one gene copy may suffer minor health issues, and those with two copies face a severe disease with no offsetting benefits.

Learn Before

Related